GLP-1s will fuel the industry’s growth in the coming years if outside forces don’t get in the way.
Can pharma sustain its $2T trajectory?
Can pharma sustain its $2T trajectory? is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: PharmaVoice